Organon
Price & Volume
Stats
See more52W Range | $6.16-$16.79 |
Market Cap | $2B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $6.3B |
Revenue Growth (YoY) | 1.3% |
Gross Profit (12 Mos) | $3.5B |
Diluted EPS | $1.91 |
News
See moreYahoo Finance • 12 days ago
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
Yahoo Finance • 14 days ago
Insider trades: Boeing, Starbucks, Merck among notable names this week
Yahoo Finance • 15 days ago
Interim Report - January-September 2025
Yahoo Finance • 19 days ago
Organon cuts outlook despite Q3 beat amid JADA divestment
About
CEO | Mr. Joseph T. Morrissey Jr. |
CFO | Mr. Matthew M. Walsh C.F.A. |
Address | 30 Hudson Street, Jersey City, NJ, United States, 07302 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 10,000 |
